Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting
Crossref DOI link: https://doi.org/10.1007/s13300-021-01053-7
Published Online: 2021-04-10
Published Print: 2021-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Uzoigwe, Chioma http://orcid.org/0000-0002-6853-7117
Liang, Yuanjie
Whitmire, Sarah
Paprocki, Yurek
Funding for this research was provided by:
Novo Nordisk Inc.
Text and Data Mining valid from 2021-04-10
Version of Record valid from 2021-04-10
Article History
Received: 18 December 2020
Accepted: 22 March 2021
First Online: 10 April 2021